C5AR2 and neoplasm: In conclusion, C5AR2 was highly expressed in BRCA, CHOL, ESCA, GBM, HNSC, KICH, LAML, LGG, LIHC, PAAD, PCPG, STAD, and THCA, indicating C5AR2 as a potential tumor target.